ISBN-10:
8847002133
ISBN-13:
9788847002135
Pub. Date:
07/29/2003
Publisher:
Springer Milan
New Advances in Heart Failure and Atrial Fibrillation: Proceedings of the Mediterranean Cardiology Meeting (Taormina, April 10-12, 2003) / Edition 1

New Advances in Heart Failure and Atrial Fibrillation: Proceedings of the Mediterranean Cardiology Meeting (Taormina, April 10-12, 2003) / Edition 1

by Michele Gulizia

Hardcover

Current price is , Original price is $169.99. You
Select a Purchase Option (2003)
  • purchase options
    $144.49 $169.99 Save 15% Current price is $144.49, Original price is $169.99. You Save 15%.
  • purchase options

Overview

New Advances in Heart Failure and Atrial Fibrillation: Proceedings of the Mediterranean Cardiology Meeting (Taormina, April 10-12, 2003) / Edition 1

Subjects of the book are Heart Failure and Atrial Fibrillation, two emerging pathologies in the field of cardiology, to which many investigators are now addressing their research. Their diffusion in the sick population represents a major public health problem at the beginning of the third millennium. The volume aims to present the latest approaches to the management of heart failure and atrial fibrillation, emphasising in particular the intrinsic relation existing between them, the results after 10 years of biventricular pacing, the innovative pacing techniques now available, and the use of new drugs, devices or ablation procedures for the prevention and treatment of atrial fibrillation recurrences.

Product Details

ISBN-13: 9788847002135
Publisher: Springer Milan
Publication date: 07/29/2003
Edition description: 2003
Pages: 443
Product dimensions: 6.10(w) x 9.25(h) x 0.04(d)

Table of Contents

Opening lecture.- Sudden Death Prevention in Heart Failure: Which Role for
ICD?. In-and outhospital management of heart failure patients.-
ACE-Inhibitors, '-Blockers, Spironolactone: Do We Need Many More Drugs to
Treat Chronic Heart Failure?. Non-Invasive Evaluation and Early Treatment of Heart Failure Patients. The Problem of Recreational Sport in Patients with Mild to Moderate Heart Failure.Wireless Home Monitoring in Permanent
Cardiac Stimulation: is it Especially Suitable in CHF Patients?.
Organisational and Economical Point of View in the Management of Congestive
Heart Failure Patient. Electromagnetic Interferences in Biventricular and/or ICD Paced Patients. Atrial Arrhythmias: Drugs, Devices or Ablation.-
Atrial Fibrillation and Flutter: Sympathetic Nervous System and
Arrhythmogenesis. Current approach and treatment in acute atrial fibrillation. Pacing, ICD, or Both for the Hybrid Therapy of Atrial
Arrhythmias?. Is There Still a Role for Right Atrial Ablation in Patients with Atrial Fibrillation?. Multidisciplinary Approach to Heart Failure and
Cardiac Resynchronization Therapy.- The Selection of Patients for Cardiac
Resynchronization Therapy. The Perspective of the Emergency Department.
Ventricular Pacing in CHF: The Role of the Internist. Atrial Fibrillation and Heart Failure: the Chicken-egg Dilemma.- Type of Therapy and Quality of
Life in Atrial Fibrillation. Ablation of Atrial Fibrillation in Chronic
Heart Failure Patient: Facts or Fancy. Risk-Stratification in Heart Failure
Patients with Varying Disease Severity. Atrial Fibrillation Therapy: From
Fiction to Facts.- Cardioversion of Recent-Onset Paroxysmal Atrial
Fibrillation to Sinus Rhythm in the Emergency Department: Comparison of
Intravenous Drugs. The Present Role And Future Perspectives Of
Radiofrequency Ablation Of Atrial Fibrillation. The Affirm Study and Its
Implications for the Pharmacological Treatment of AF. Antiarrhythmic Agents in Atrial Fibrillation: A New Role in the Context of a Hybrid Approach?
State of the Art in the Current Trends and Treatments of Atrial
Fibrillation and Flutter.- Atrial Fibrillation: New Insights Into
Electrophysiologic Mechanisms. Pharmacological therapy of atrial fibrillation and flutter: advances and limitations of specific antiarrhythmic drugs. Atrial Fibrillation and Flutter: the Latest from the
Planet of Right RF Catheter Ablation. Hot Topics in Tachyarrhythmias management.- Impact of LocaLisa on Ablation Management. Device Therapy for
Atrial Arrhythmias: Latest Topics from the AT500 Italian Registry. The Role of Electrical Therapy in Patients with Left Ventricular Dysfunction.- Role of Electrical Therapy in Patients with Left Ventricular Dysfunction: The
Clinical Cardiologist's Experience. The Electrophysiological Aspect. New
Approaches in Electrical Treatment and Management of Heart Failure
Patients.-Benefits of Closed Loop Stimulation in Resynchronization Therapy.
Optimization Of Resynchronization Therapy By Intracardiac Ventricular
Impedance.Dual Site Right Ventricular Pacing in Heart Failure Patients.The role of 'single shock' ICD for sudden death primary prevention in heart failure patients. Biventricular Pacing: A Simplified Technique For
Transvenous Implantation. Innovative Pacing Techniques: Solutions for AF
and HF.- Pacing in Atrial Fibrillation: Therapies for Rhythm Control.Pacing in Atrial Fibrillation: Therapies for Rate Control.What Have We Learned from Cardiac Resynchronization Trials?.Is There Still a Role for
Cardioversion in AF Patients?.-Is Fluoroscopic Electrode Positioning
Improving the Clinical Efficacy of External Biphasic Cardioversion in patients with AF?.Is Transesophageal Echocardiography Always Necessary
Before Cardioversion of AF Patients After Conventional Anticoagulation
Therapy?.Anticoagulation Therapy of Atrial Fibrillation in the Elderly.
Ultimate and Ongoing Trials on Heart Failure.-Pharmacological Trials on
Heart Failure: What Can We Translate into Daily Clinical Practice?.A Review of the SCD-HEFT, Companion, and CARE-HF Trials. Management of Atrial
Fibrillation Suppression in AF-HF Comorbidity Therapy (MASCOT) Trial. New
ICD Perspectives in the CHF Patient. Implantable Devices for Atrial
Arrhythmias.- Role of the Implantable Loop Recorder in the Management of
Patients with Atrial Fibrillation. Atrial Pacing Algorithms for the
Prevention of Atrial Fibrillation. Treatment of Atrial Fibrillation in
Patients Affected by Sinus Bradycardia: Role of Prevention and
Antitachycardia Pacing Algorithms. Recent and Ongoing Trials on Device
Therapy of Atrial Fibrillation. Criteria for Selection of Patients with
Atrial Fibrillation to Receive a Dual-Site ICD.New Concepts in the
Treatment of AF.-Risk Stratification in Atrial Fibrillation and Congestive
Heart Failure.Rhythm-control versus rate-control, strategy:unresolved riddle in daily clinical practice. Amiodarone in the Treatment of Atrial
Fibrillation: New Perspectives from Clinical Trials. 10-year of biventricular pacing in CHF.- Echocardiography in the Identification of
Responders: The Novel Role of Tissue Doppler Imaging and Strain Imaging.
When and which CHF patient needs to be studied in haemodynamic laboratory?
How To Follow The Resynchronised Paced Patients. Biventricular Pacing with
ICD Backup: A Luxury or a Necessity—. BiventricularCardiac
Resynchronization in Moderate-to-Severe Heart Failure: Analysis of Hospital
Costs and Clinical Effectiveness (Brescia Study). Hybrid Therapy in AF and
HF.- Drugs as Pretreatment before Electrical Cardioversion. Drugs and
Pacemakers in Patients with AF and HF. Drugs and Implantable Cardioverter
Defibrillators .Drugs and ablation in atrial fibrillation and heart failure patients. Can Ventricular Resynchronization Reduce Atrial Fibrillation
Recurrences?.

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews